Biorchestra Co., Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jun 2039
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jun 12, 2027The maintenance fee for Micellar nanoparticles and uses thereof (US 11,839,624) comes due Jun 12, 2027. Unpaid by Dec 13, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 5 of 5
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,844,380 | Uses for prevention or treatment of brain diseases using microrna In force · USPTO record | In force | USPTO record | |
| US 11,198,908 | Method for diagnosis of Alzheimer's disease using microRNA In force · USPTO record | In force | USPTO record | |
| US 11,542,503 | Uses for prevention or treatment of brain diseases using microRNA In force · USPTO record | In force | USPTO record | |
| US 12,084,718 | Method for diagnosis of Alzheimer's disease using microrna In force · USPTO record | In force | USPTO record | |
| US 11,839,624 | Micellar nanoparticles and uses thereof In force · USPTO record | In force | USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 5 abandoned · 14 no status recorded
Showing 1 to 10 of 21, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/503,748 | Nov 7, 2023 | No status recorded | |
| 18/881,645 | Jul 6, 2023 | No status recorded | |
| 18/149,251 | Jan 3, 2023 | No status recorded | |
| 18/145,352 | Dec 22, 2022 | No status recorded | |
| 18/555,304 | Polynucleotides Capable of Enhanced Protein Expression and Uses Thereof | Apr 15, 2022 | Abandoned |
| 18/264,354 | Use of MIRNA-485 Inhibitors for Treating Diseases or Disorders Associated with Abnormal NLRP3 Expression | Feb 5, 2022 | Abandoned |
| 18/264,351 | Feb 5, 2022 | Abandoned | |
| 18/259,622 | Micellar Nanoparticles and Uses Thereof | Dec 30, 2021 | Abandoned |
| 18/259,618 | Micellar Nanoparticles and Uses Thereof | Dec 29, 2021 | Pending |
| 18/259,007 | Dec 23, 2021 | No status recorded |
10 of 21 applications shown.
Pro members see all 21 published applications.